Title : Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy - |
Author(s) :
Yiu DC , Lin H , Wong VW , Wong GL , Liu K , Yip TC |
Ref :
Clin Mol Hepatol , : , 2024 |
PubMedID: 38964740 |